Functional Dietary Components, Gut Microbiota, and Host Health: Interaction Mechanisms and Innovative Product Development

A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Gut Microbiota".

Deadline for manuscript submissions: 31 May 2026 | Viewed by 2301

Special Issue Editor


E-Mail Website
Guest Editor
Department of Food Science and Technology, College of Science and Engineering, Jinan University, Guangzhou, China
Interests: polysaccharide characterization; polysaccharide degradation; bioactivity and function of polysaccharides; gut microbiota
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Functional dietary components, such as bioactive compounds, dietary fibers, prebiotics, probiotics, and postbiotics, play crucial roles in maintaining host health and preventing chronic diseases. Increasing evidence indicates that the gut microbiota acts as a key intermediary between diet and host physiology, influencing metabolic homeostasis, immune modulation, and even neurobehavioral functions. The interaction between functional dietary components and the gut microbiota has, therefore, emerged as a central topic in nutritional science and health research. Understanding these complex mechanisms provides important opportunities for the development of innovative functional foods and personalized nutrition strategies. However, our current understanding of how functional dietary components regulate the gut microbiota and its derived metabolites to affect host health remains limited. Major challenges include identifying the specific microbial taxa, metabolites, and molecular pathways that mediate these beneficial effects, as well as establishing causal relationships between dietary interventions and physiological outcomes. Furthermore, translating mechanistic insights into practical applications, such as targeted product development, microbiome-based dietary interventions, and personalized nutrition, requires comprehensive and integrative research approaches.

This Research Topic aims to gather the latest studies that elucidate the interaction mechanisms between functional dietary components, gut microbiota, and host health, and to promote innovative research on the design and development of functional foods. Understanding how dietary components shape gut microbial ecosystems and influence host biological processes will provide a strong scientific basis for the next generation of microbiome-targeted nutritional strategies.

We welcome submissions of Original Research, Full Reviews, Mini Reviews, and Perspectives that focus on, but are not limited to, the following topics:

  1. Individual differences in gut microbiota response to functional dietary components and their implications for host health.
  2. Identification of key microbial taxa, metabolites, and signaling molecules mediating the effects of dietary components on health outcomes.
  3. Application of high-throughput multi-omics (metagenomics, metabolomics, transcriptomics, etc.) and advanced bioinformatics approaches (e.g., systems biology and artificial intelligence) to elucidate diet–microbiota–host interactions.
  4. Molecular mechanisms underlying the modulation of metabolic, immune, and neurophysiological pathways by microbial metabolites.
  5. Translational research on the development of innovative functional foods, probiotics, synbiotics, and postbiotics targeting gut health.
  6. Integration of microbiome science into precision nutrition approaches for disease prevention and health promotion.

Dr. Zhenjun Zhu
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • prebiotics
  • probiotics
  • postbiotics
  • gut microbiota
  • host health

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

10 pages, 841 KB  
Article
Multi-Model Longevity Assays Reveal Lifespan- and Healthspan-Promoting Effects of Bacillus subtilis WTC019
by Nan Zheng, Zhanlei Fan, Yangzhou Diao, Xiangyu Li, Yan Zhang, Bohui Shi, Jinshan Li and Shouyong Ju
Microorganisms 2026, 14(2), 314; https://doi.org/10.3390/microorganisms14020314 - 29 Jan 2026
Viewed by 693
Abstract
Bacillus subtilis is a spore-forming probiotic with an established safety profile, yet its effects on aging-related phenotypes remain incompletely defined. Here, we assessed the lifespan- and healthspan-promoting activity of a novel strain, B. subtilis WTC019, using integrated invertebrate, cellular, and mammalian aging models. [...] Read more.
Bacillus subtilis is a spore-forming probiotic with an established safety profile, yet its effects on aging-related phenotypes remain incompletely defined. Here, we assessed the lifespan- and healthspan-promoting activity of a novel strain, B. subtilis WTC019, using integrated invertebrate, cellular, and mammalian aging models. In Caenorhabditis elegans, B. subtilis WTC019 significantly extended lifespan, increasing median lifespan by 17.48%, 90% lifespan by 35.36%, and maximum lifespan by 19.07%, and attenuated age-associated locomotor decline. In human skin fibroblasts, B. subtilis WTC019 cell lysate reduced senescence-associated β-galactosidase activity by approximately 34% and altered cell cycle distribution consistent with delayed cellular senescence. Moreover, dietary supplementation with B. subtilis WTC019 significantly prolonged lifespan in C57BL/6J mice, with median lifespan increases of 5.97% in females and 6.05% in males. Together, these results demonstrate that B. subtilis WTC019 promotes lifespan- and healthspan-associated phenotypes across multiple aging models, supporting its potential as a probiotic candidate for healthy aging interventions. Full article
Show Figures

Figure 1

16 pages, 3790 KB  
Article
Multi-Kingdom Gut Microbiome Interaction Characteristics Predict Immune Checkpoint Inhibitor Efficacy Across Pan-Cancer Cohorts
by Tong Qiao and Zhenjun Zhu
Microorganisms 2025, 13(11), 2595; https://doi.org/10.3390/microorganisms13112595 - 14 Nov 2025
Cited by 1 | Viewed by 1360
Abstract
An increasing number of studies have confirmed that the gut microbiota, especially bacteria, is closely related to the efficacy of immune checkpoint inhibitor (ICI) therapy. However, the effectiveness of multi-kingdom microbiota and their interactions in predicting the therapeutic effect of ICI therapy remains [...] Read more.
An increasing number of studies have confirmed that the gut microbiota, especially bacteria, is closely related to the efficacy of immune checkpoint inhibitor (ICI) therapy. However, the effectiveness of multi-kingdom microbiota and their interactions in predicting the therapeutic effect of ICI therapy remains uncertain. We integrated extensive gut metagenomic databases, including 1712 samples of 10 cohorts from 7 countries worldwide, to conduct rigorous differential analysis and co-occurrence network analysis targeting multi-kingdom microbiota (bacteria, fungi, archaea, and virus). We ultimately identified two subtypes (C1 and C2) by employing a weighted similarity network fusion (WSNF) method. Subtype C2 exhibited higher microbial diversity, better treatment response, and improved prognosis compared to subtype C1. Notably, subtype C2 was associated with higher abundance of beneficial genera such as Bacteroides and Kluyveromyces, while subtype C1 contained potentially detrimental taxa like Malassezia. A multi-kingdom model incorporating 32 genera demonstrated superior predictive accuracy for ICI therapy efficacy compared to single-kingdom models. Co-occurrence network analysis revealed a more robust and interconnected microbiome in subtype C2, suggesting a stable gut environment correlates with effective ICI therapy efficacy. This study highlights the potential of a multi-kingdom signature in predicting the efficacy of ICI therapy, offering a novel perspective for personalized therapy in oncology. Full article
Show Figures

Figure 1

Back to TopTop